Josh Ddd @GitRDone73
14 May, 11:55
Wanna know what all these drugs have in common?

They’re all anti-parasitic and they’re all anti-cancer

Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells by inhibiting the AKT/mTOR Signalling Pathway
https://www.jcancer.org/v1...

Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway
https://pubmed.ncbi.nlm.ni...

The anthelmintic agent oxfendazole inhibits cell growth in non‑small cell lung cancer by suppressing c‑Src activation
https://www.spandidos-publ...

Ivermectin Antiparasitic Anticancer Wonder Drug
https://jeffreydachmd.com/...

The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug

https://www.ncbi.nlm.nih.g...

Unexpected antitumorigenic effect of fenbendazole

https://pubmed.ncbi.nlm.ni...

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Josh Ddd @GitRDone73
14 May, 11:55
In response Josh Ddd to his Publication
A Drug For Animals Now Taken By Humans For Cancer: Fenbendazole
https://principia-scientif...

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
https://www.ncbi.nlm.nih.g...

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents
https://www.ncbi.nlm.nih.g...

Mebendazole as a Candidate for Drug Repurposing in Oncology
https://www.ncbi.nlm.nih.g...

Niclosamide Exhibits Potent Anticancer Activity
https://pubmed.ncbi.nlm.ni...

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Josh Ddd @GitRDone73
Molecular mechanisms of niclosamide antitumor activity
https://pubmed.ncbi.nlm.ni...

Niclosamide: Beyond an antihelminthic drug
https://www.ncbi.nlm.nih.g...

Oxibendazole inhibits prostate cancer cell growth
https://www.spandidos-publ...

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents
https://pubmed.ncbi.nlm.ni...
11:55 AM - May 14, 2022
In response Josh Ddd to his Publication
Only people mentioned by GitRDone73 in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Josh Ddd, click on at the bottom under it